Skip to main content
NVDA-0.53%AAPL-0.82%GOOGL+0.74%MSFT-0.84%AMZN-0.31%TSM+0.32%SPCX-3.23%AVGO+1.81%TSLA-1.28%META-1.70%LLY+0.46%BRK-B0.00%SKHY+12.62%MU+4.14%WMT-0.19%AMD+1.84%JPM+0.97%V+0.08%XOM+1.66%JNJ+1.08%ASMLa+1.33%MA+0.49%ABBV+0.44%INTC+0.58%1398.HK+0.13%CVX+1.27%0700.HK+0.62%COST-0.69%CSCO-1.22%KO+0.56%ORCL+5.40%UNH-0.50%PG-0.26%BAC+0.33%1816.HK-1.08%3988.HK-0.33%CAT+0.28%AMAT+4.89%AP2d+4.38%PM+0.31%HD-0.19%LRCX+5.12%DELL-1.58%0857.HK-1.09%GE+1.46%0939.HK-0.80%1288.HK+0.30%NVS-0.67%0005.HK+0.97%MS+1.36%NZDUSD-1.51%AUDNZD+1.50%NZDCAD-1.25%NZDMXN-1.13%NZDSGD-1.03%GBPNZD+0.93%USDJPY+0.93%AUDJPY+0.91%NZDCHF-0.90%EURNZD+0.86%NOKJPY+0.83%CHFNOK-0.73%CADJPY+0.66%EURUSD-0.65%USDCHF+0.65%AUDCHF+0.65%EURAUD-0.63%NZDJPY-0.62%USDNOK-0.60%GBPUSD-0.60%GBPAUD-0.58%EURNOK-0.55%AUDNOK-0.47%GBPTRY+0.41%CADCHF+0.37%EURCAD-0.36%EURZAR+0.36%GBPCAD-0.33%GBPJPY+0.32%GBPHKD+0.32%USDZAR+0.31%CHFSEK-0.29%CHFJPY+0.29%AUDSGD+0.29%EURJPY+0.29%GBPMXN-0.28%USDCAD+0.28%USDTRY+0.27%AUDCAD+0.26%GBPZAR+0.22%EURSGD+0.22%EURCZK+0.18%USDSEK-0.17%EURPLN+0.17%USDILS+0.16%USDSGD+0.16%USDPLN+0.12%EURSEK-0.12%PLNJPY+0.11%GBPSGD+0.08%AUDDKK+0.06%EURHKD+0.06%SGDJPY+0.06%USDDKK-0.06%USDTHB+0.05%USDMXN+0.05%EURCNH+0.05%EURGBP-0.05%USDHKD+0.05%GBPCHF+0.04%USDCOP-0.04%USDCNH-0.04%CHFSGD+0.03%AUDUSD-0.02%EURCHF-0.02%EURDKK-0.01%USOIL+2.71%UKOIL+1.74%XAGUSD-1.69%GAGUSD-1.69%XPTUSD-0.71%XAUUSD-0.67%GAUUSD-0.67%HG1-0.14%XNGUSD+0.03%COFFEE0.00%COCOA0.00%COTTON0.00%BTCUSD-0.01%ETHUSD+22.55%USDTUSD0.00%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT-0.36%ZECUSDT-1.90%DOGEUSD+18.62%XMRUSDT-1.12%LINKUSD+23.58%BCHUSDT-4.88%XLMUSD-0.11%UNIUSD+0.34%LTCUSD+16.21%SUIUSD-0.76%HBARUSDT-1.80%TONUSD+39.55%TAOUSDT-0.89%AAVEUSD-0.91%DOTUSDT-0.40%ICPUSDT-0.28%ONDOUSDT-1.38%WLDUSDT-3.31%ARBUSDT+0.23%JUPUSDT-0.75%ATOMUSDT-0.81%INJUSDT-2.32%STXUSDT-1.71%TIAUSDT-1.73%FETUSDT-0.98%PYTHUSDT-2.53%SEIUSDT-0.79%IMXUSDT-1.78%GRTUSDT-1.06%OPUSDT-1.19%WIFUSDT+0.28%IOTAUSDT-3.51%POLUSDT-1.36%AXSUSDT-1.44%EOSUSDT-0.10%FARTCOINUSDT-1.62%DYDXUSDT+0.18%GALAUSDT-0.96%ORDIUSDT-1.98%RONINUSDT-2.72%NOTUSDT+0.18%NVDA-0.53%AAPL-0.82%GOOGL+0.74%MSFT-0.84%AMZN-0.31%TSM+0.32%SPCX-3.23%AVGO+1.81%TSLA-1.28%META-1.70%LLY+0.46%BRK-B0.00%SKHY+12.62%MU+4.14%WMT-0.19%AMD+1.84%JPM+0.97%V+0.08%XOM+1.66%JNJ+1.08%ASMLa+1.33%MA+0.49%ABBV+0.44%INTC+0.58%1398.HK+0.13%CVX+1.27%0700.HK+0.62%COST-0.69%CSCO-1.22%KO+0.56%ORCL+5.40%UNH-0.50%PG-0.26%BAC+0.33%1816.HK-1.08%3988.HK-0.33%CAT+0.28%AMAT+4.89%AP2d+4.38%PM+0.31%HD-0.19%LRCX+5.12%DELL-1.58%0857.HK-1.09%GE+1.46%0939.HK-0.80%1288.HK+0.30%NVS-0.67%0005.HK+0.97%MS+1.36%NZDUSD-1.51%AUDNZD+1.50%NZDCAD-1.25%NZDMXN-1.13%NZDSGD-1.03%GBPNZD+0.93%USDJPY+0.93%AUDJPY+0.91%NZDCHF-0.90%EURNZD+0.86%NOKJPY+0.83%CHFNOK-0.73%CADJPY+0.66%EURUSD-0.65%USDCHF+0.65%AUDCHF+0.65%EURAUD-0.63%NZDJPY-0.62%USDNOK-0.60%GBPUSD-0.60%GBPAUD-0.58%EURNOK-0.55%AUDNOK-0.47%GBPTRY+0.41%CADCHF+0.37%EURCAD-0.36%EURZAR+0.36%GBPCAD-0.33%GBPJPY+0.32%GBPHKD+0.32%USDZAR+0.31%CHFSEK-0.29%CHFJPY+0.29%AUDSGD+0.29%EURJPY+0.29%GBPMXN-0.28%USDCAD+0.28%USDTRY+0.27%AUDCAD+0.26%GBPZAR+0.22%EURSGD+0.22%EURCZK+0.18%USDSEK-0.17%EURPLN+0.17%USDILS+0.16%USDSGD+0.16%USDPLN+0.12%EURSEK-0.12%PLNJPY+0.11%GBPSGD+0.08%AUDDKK+0.06%EURHKD+0.06%SGDJPY+0.06%USDDKK-0.06%USDTHB+0.05%USDMXN+0.05%EURCNH+0.05%EURGBP-0.05%USDHKD+0.05%GBPCHF+0.04%USDCOP-0.04%USDCNH-0.04%CHFSGD+0.03%AUDUSD-0.02%EURCHF-0.02%EURDKK-0.01%USOIL+2.71%UKOIL+1.74%XAGUSD-1.69%GAGUSD-1.69%XPTUSD-0.71%XAUUSD-0.67%GAUUSD-0.67%HG1-0.14%XNGUSD+0.03%COFFEE0.00%COCOA0.00%COTTON0.00%BTCUSD-0.01%ETHUSD+22.55%USDTUSD0.00%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT-0.36%ZECUSDT-1.90%DOGEUSD+18.62%XMRUSDT-1.12%LINKUSD+23.58%BCHUSDT-4.88%XLMUSD-0.11%UNIUSD+0.34%LTCUSD+16.21%SUIUSD-0.76%HBARUSDT-1.80%TONUSD+39.55%TAOUSDT-0.89%AAVEUSD-0.91%DOTUSDT-0.40%ICPUSDT-0.28%ONDOUSDT-1.38%WLDUSDT-3.31%ARBUSDT+0.23%JUPUSDT-0.75%ATOMUSDT-0.81%INJUSDT-2.32%STXUSDT-1.71%TIAUSDT-1.73%FETUSDT-0.98%PYTHUSDT-2.53%SEIUSDT-0.79%IMXUSDT-1.78%GRTUSDT-1.06%OPUSDT-1.19%WIFUSDT+0.28%IOTAUSDT-3.51%POLUSDT-1.36%AXSUSDT-1.44%EOSUSDT-0.10%FARTCOINUSDT-1.62%DYDXUSDT+0.18%GALAUSDT-0.96%ORDIUSDT-1.98%RONINUSDT-2.72%NOTUSDT+0.18%
OT

Oruka Therapeutics, Inc. (ORKA)

NASDAQ • Healthcare

$95.81
+$5.48 (+6.1%)
Market open

Last close at October 27, 2026 at 20:00 UTC

Open$89.02
Previous Close$95.81
Day Range$89.02 - $96.66
Avg. Volume (3M)978.7K
Market Cap$6.3B
52 Week Range
$25.23$115.52
Next EarningsIn 14 daysNov 11, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$132.8M
EPS (TTM)
-$2.47
ROA (TTM)
-11.66%
Current Ratio
38.51
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+26.2%Q1 2026-$0.45
+12.2%Q2 2026-$0.48
-7.3%Q3 2026-$0.55
Next

Nov 11

in 14 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -7.3%

Oruka Therapeutics’ preliminary results for the second fiscal quarter of 2026 showed adjusted EPS of -$0.55, which trailed the -$0.51 estimate (-7%), when it reported on August 10, 2026. On a year-over-year basis, adjusted EPS was down -19.6% from -$0.46 a year ago, alongside a GAAP net loss of roughly $41.2 million, down -67.7% from roughly $24.6 million in the prior-year period. The company also posted GAAP operating income of around -$50.1 million for the quarter, and it reported negative operating cash flow of about $33.1 million. For the next period, consensus calls for EPS of -$0.59.

Next report — what to expect

Oruka Therapeutics, Inc. (ORKA) is set to report on November 11, 2026. Consensus calls for EPS of -$0.599. The company has beaten EPS expectations in 6 of 8 most recent quarters, so traders may focus on any commentary around drivers of the quarter and updates that could influence future results.

View full earnings history

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. is a NASDAQ-listed biotechnology company in the healthcare sector that develops monoclonal antibody medicines for psoriasis and other inflammatory and immunology conditions. In qualitative terms, it is a clinical-stage business built around a small pipeline of named antibody programs rather than a marketed-product portfolio.

Name
Oruka Therapeutics, Inc.
CEO
Lawrence Otto Klein
Website
www.orukatx.com
Industry
Healthcare
Employees
68

Today's Snapshot

AI-generated

ORKA is trading 0.8% below yesterday's close, while its sector was flat. Earnings are due from ORKA on 11 November.

Trading Volume

Below 10d avg (979.1K)

369.8K

vs S&P 500 Today

Underperforming Market

-0.97%

Updated: October 28, 2026 at 17:01 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
ORKA displays a strong bullish technical alignment: the price is above short-, medium- and long-term moving averages and ADX indicates a trending market. Momentum measures are broadly positive — CCI and short-term momentum are notably strong and MACD is positive — while RSI sits in bullish territory. Volume supports the move with a healthy positive OBV, although ATR and the Bollinger band reading point to elevated volatility at current levels. The classic pivot is just below the market, offering nearby support. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$67.42 - $86.24
    Buy
  • RSI (14)64.64
    Neutral
  • Stochastic %K (14, 3, 3)90.24
    Sell
  • MACD Level (12, 26)0.41
    Buy

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$79.52+0.2%
XNCRXencor, Inc.
$29.99+2.8%
ANABAnaptysBio, Inc.
$49.63+1.8%
ALMSAlumis Inc.
$6.64+2.0%
MLTXMoonLake Immunotherapeutics
ODTXOdyssey Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.